Kroeger Christopher A. 4

What Happened Christopher A. Kroeger, CEO of MapLight Therapeutics (MPLT), had 204,146 shares withheld by the issuer to satisfy tax withholding obligations related to the settlement of restricted stock units. The withholding is reported as a disposition at an average per‑share value of $17.98, for a total of $3,670,545. This was a tax‑withholding cashless disposition (transaction code F), not an open‑market sale.

Key Details

• Transaction date: January 27, 2026; Filing date: January 29, 2026 (appears timely).
• Shares withheld/disposed: 204,146 at $17.98 per share; total value reported $3,670,545.
• Shares owned after transaction: Not specified in this filing.
• Footnotes:
  • F1: Shares were withheld by the issuer to satisfy tax withholding on RSU settlement; retained securities remain subject to a 180‑day IPO lock‑up tied to the Oct 26, 2025 final prospectus (lock‑up ends ~Apr 24, 2026).
  • F2: Shares are held by the C&M Kroeger Nominee Trust; Kroeger is co‑trustee with his spouse and has voting and dispositive power.
• Transaction code meaning: F = payment of exercise price or tax liability (share withholding).

Context This was a routine tax‑withholding transaction following an RSU settlement (a common cashless method where the issuer retains shares to cover taxes). Such withholdings are administrative and do not necessarily indicate a decision by the insider to sell shares for other reasons. Purchases or open‑market sales generally carry more direct signals about insider sentiment.